Le médecin a obtenu son diplôme de l'École de médecine Cerrahpaşa de l'Université d'Istanbul en 2000 et a terminé sa résidence en médecine interne à l'Université d'Ankara en 2004, obtenant le titre d'interniste. Avec une carrière académique prolifique, le médecin a contribué à 19 articles internationaux, 6 articles locaux et a présenté lors de 25 congrès locaux et internationaux. Le médecin a reçu les prix de la meilleure présentation orale et du meilleur poster au 7ème Congrès international sur les cancers du système gastro-intestinal.<\/p>
Spécialisé dans les procédures endoscopiques avancées, le médecin se concentre sur des traitements tels que le POEM pour l'achalasie, l'ESD pour les cancers gastro-intestinaux à un stade précoce, l'ERCP pour le traitement des voies biliaires, le Z-POEM pour le diverticule de Zenker et le G-POEM pour la gastroparésie.<\/p>
Le médecin est un oncologue et chirurgien général expérimenté avec plus de 25 ans d'expérience, spécialisé dans le traitement du cancer et les transplantations d'organes. Reconnu pour ses contributions significatives dans le domaine, le médecin a reçu de nombreux prix, y compris le prix AACR Scholar-in-Training et le Certificat de Réalisation Exceptionnelle en Transplantation Hépatique. Le médecin est membre actif de plusieurs associations prestigieuses, y compris la Société Américaine du Cancer du Sein et l'Association de Chirurgie Oncologique, où il siège au conseil d'administration.<\/p>
Le médecin détient un diplôme de M.Sc de la Faculté de Médecine de l'Université de Çukurova et a complété un doctorat/spécialité en Chirurgie Générale à l'Hôpital de Formation et de Recherche Ankara Numune.<\/p>
Chronic hepatitis B is not currently curable but is highly manageable through viral suppression. Turkish JCI-accredited hospitals provide antiviral protocols using Tenofovir or Entecavir. These therapies reduce viral load to prevent cirrhosis and liver cancer while maintaining long-term liver function.
Bookimed Expert Insight: Turkey's infrastructure is built for high-volume liver care. Medipol Mega University Hospital serves over 1,000,000 patients annually. This massive scale ensures doctors have extensive experience managing complex viral loads. Choosing a multi-specialty center with 70+ departments allows for faster coordination if liver complications arise.
Patient Consensus: Patients emphasize that long-term monitoring and regular blood tests are the most critical parts of the journey. Many note that the emotional relief of lowering their viral load is as important as the physical treatment.
Top Turkish hospitals for Hepatitis B treatment include Medipol Mega University Hospital, Memorial Şişli Hospital, and Anadolu Medical Center. These JCI-accredited facilities offer specialized gastroenterology and infectious disease departments. They provide essential long-term antiviral therapy, viral load monitoring, and advanced liver fibrosis staging.
Bookimed Expert Insight: Patients seeking HBV care should prioritize hospitals with high-volume organ transplant departments, like Memorial Şişli or Medipol. These centers possess the most advanced hepatology infrastructure. They often have more experience managing complex liver damage. This expertise ensures precise monitoring even if you do not require surgery.
Patient Consensus: Patients value doctors who emphasize long-term monitoring over immediate procedures. They note that choosing a major teaching hospital ensures more thorough liver enzyme and viral load tracking.
Chronic hepatitis B management requires suppression of the virus through long-term antiviral medication and regular liver monitoring. Turkish centers focus on using high-potency drugs like entecavir or tenofovir. Lifelong surveillance every 6 to 12 months is necessary to maintain a 99% survival rate by preventing cirrhosis.
Bookimed Expert Insight: Turkish JCI-accredited hospitals like Memorial Şişli and Anadolu Medical Center offer integrated oncology and transplant units. This infrastructure is vital because chronic management occasionally transitions into complex care. While many clinics serve thousands, these specific centers maintain 90% success rates for high-risk liver procedures.
Patient Consensus: Patients emphasize that staying with a consistent specialist clinic in Turkey is crucial for long-term tracking. They note that consistent medication adherence is vital to avoid dangerous viral rebounds or liver flare-ups.
The first visit for hepatitis B focuses on status confirmation and liver health assessment. Patients meet with a gastroenterologist or infectious disease specialist at JCI-accredited Turkish hospitals. The evaluation includes viral load testing, liver enzyme analysis, and non-invasive imaging like transient elastography to determine if immediate medication is necessary.
Bookimed Expert Insight: Turkish oncology and hepatology centers like Anadolu Medical Center benefit from high patient volumes. They serve over 65,000 patients annually. This massive data set allows specialists to differentiate between immune-active and inactive hepatitis B more accurately. High-volume clinics often provide more reliable long-term monitoring schedules due to their extensive experience with international case variations.
Patient Consensus: Patients note that the first visit is very test-heavy. They emphasize bringing previous lab records to help doctors track the virus's stability over time.
Liver transplantation is a primary treatment for HBV-related end-stage liver disease in Turkey. Chronic Hepatitis B causes over 35% of all liver transplants in the country. Turkish JCI-accredited centers perform living and cadaveric surgeries with success rates reaching 90% for organ transplants.
Bookimed Expert Insight: Turkish transplantation centers demonstrate high technical proficiency by managing massive patient volumes. Medipol Mega and Hisar Hospital together serve over 1,500,000 patients yearly. This high frequency allows surgical teams to maintain peak clinical precision. Most top-rated hospitals are located in Istanbul, which simplifies logistics for international families.
Patient Consensus: Patients note that controlling the virus before surgery is essential for qualifying for a transplant. Reliable long-term monitoring and a solid plan for lifelong antiviral medicine are vital for preventing recurrence.